Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioLife Solutions, Inc. - Common Stock
(NQ:
BLFS
)
19.83
+0.66 (+3.44%)
Streaming Delayed Price
Updated: 3:08 PM EDT, Mar 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioLife Solutions, Inc. - Common Stock
< Previous
1
2
3
Next >
Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million
↗
February 27, 2026
Relay Therapeutics develops precision medicines targeting oncology and genetic diseases, leveraging proprietary computational technology.
Via
The Motley Fool
Topics
Regulatory Compliance
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million
↗
February 27, 2026
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
Via
The Motley Fool
Topics
Regulatory Compliance
BioLife Solutions Inc (NASDAQ:BLFS) Surpasses Q4 2025 Estimates with Surprise Profit, Stock Rises
↗
February 26, 2026
Via
Chartmill
BioLife (BLFS) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
BioLife (BLFS) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Exploring BioLife Solns's Earnings Expectations
↗
May 07, 2025
Via
Benzinga
BioLife Solutions' CFO Sells 30,000 Shares
↗
December 11, 2025
This bioproduction tools provider for cell and gene therapy reported a notable insider sale.
Via
The Motley Fool
Topics
Regulatory Compliance
BioLife (BLFS) Q3 2025 Earnings Call Transcript
↗
November 09, 2025
BioLife (BLFS) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
BioLife Solutions Inc (NASDAQ:BLFS) Beats Q3 2025 Earnings and Revenue Estimates
↗
November 06, 2025
BioLife Solutions Q3 2025 earnings beat estimates with a surprise profit and strong revenue growth, driving a positive market response.
Via
Chartmill
Topics
Earnings
BioLife Solutions Inc (NASDAQ:BLFS) Reports Mixed Q2 2025 Results with Revenue Beat but Profitability Concerns
↗
August 07, 2025
BioLife Solutions reports Q2 2025 revenue beat but faces profitability challenges, with mixed market reaction. Cell processing growth up 28% YoY.
Via
Chartmill
Earnings Scheduled For March 3, 2025
↗
March 03, 2025
Via
Benzinga
Analyst Expectations For BioLife Solns's Future
↗
November 18, 2024
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Key Takeaways From BioLife Solns Analyst Ratings
↗
September 30, 2024
Via
Benzinga
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024
↗
May 09, 2024
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling
↗
April 19, 2024
Via
Benzinga
Recap: BioLife Solns Q4 Earnings
↗
February 29, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
↗
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Earnings Preview For BioLife Solns
↗
February 28, 2024
Via
Benzinga
BioLife Solns: Q3 Earnings Insights
↗
November 09, 2023
Via
Benzinga
Over $1M Bet On Carnival? Check Out These 3 Stocks Insiders Are Buying
↗
October 24, 2023
Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.
Via
Benzinga
Top 5 Health Care Stocks That Could Blast Off This Month
↗
August 21, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Why Shares of BioLife Solutions Plummeted This Week
↗
August 11, 2023
The company saw revenue decline, year over year, in the second quarter.
Via
The Motley Fool
Why Shares of BioLife Solutions Are Slumping on Wednesday
↗
August 09, 2023
The company reported declining revenue and reduced annual guidance.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 09, 2023
Via
Benzinga
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
↗
August 09, 2023
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 09, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
